Dec 10, 2021 / NTS GMT
Sebastian Frericks - Carl Zeiss Meditec AG - Director of IR
Good morning, ladies and gentlemen. Thank you for joining us today. Welcome to our analyst conference of Carl Zeiss Meditec AG. I'm Sebastian, I'm the Head of Investor Relations. And with me, as usual, I am delighted to have with me today, our President and CEO, Dr. Ludwin Monz; Ludwin, welcome; our CFO, Justus Wehmer, on the other side; welcome, Justus. And 2 special guests, Dr. Markus Weber, our new designated CEO as of January, who will briefly introduce himself today; and Dr. Euan Thomson, the Head of our Ophthalmic Devices segment, who also I'm very thrilled to have him join us today for this presentation.
I would like to hand over now to our Executive Board to give you an introduction to the financials of the 12 months 2021. After that, we'll have a strategy presentation on our cataract and digital strategy by Euan Thomson. And after that, we look forward to your questions.
I'll explain this again in the course of the presentation. But just let me get it out of the way right now. One technical feature to consider, which
Q4 2021 Carl Zeiss Meditec AG Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot